title: Multiple eruptive dermatofibromas in a patient receiving efalizumab.
authors.forename: Jorge
authors.initials: J
authors.lastname: Santos-Juanes
authors.forename: Pablo
authors.initials: P
authors.lastname: Coto-Segura
authors.forename: Susana
authors.initials: S
authors.lastname: Mallo
authors.forename: Cristina
authors.initials: C
authors.lastname: Galache
authors.forename: Jorge
authors.initials: J
authors.lastname: Soto
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab